Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2020 | 3 |
2021 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus.
Front Immunol. 2020 Jan 9;10:3018. doi: 10.3389/fimmu.2019.03018. eCollection 2019.
Front Immunol. 2020.
PMID: 31998305
Free PMC article.
Synergistic effect of non-neutralizing antibodies and interferon-γ for cross-protection against influenza.
Shibuya M, Tamiya S, Kawai A, Hirai T, Cragg MS, Yoshioka Y.
Shibuya M, et al.
iScience. 2021 Sep 15;24(10):103131. doi: 10.1016/j.isci.2021.103131. eCollection 2021 Oct 22.
iScience. 2021.
PMID: 34622175
Free PMC article.
Item in Clipboard
Nasal-subcutaneous prime-boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections.
Shibuya M, Tamiya S, Kawai A, Yoshioka Y.
Shibuya M, et al.
Biochem Biophys Res Commun. 2021 May 21;554:166-172. doi: 10.1016/j.bbrc.2021.03.099. Epub 2021 Mar 30.
Biochem Biophys Res Commun. 2021.
PMID: 33798943
Item in Clipboard
Lipid Nanoparticle Acts as a Potential Adjuvant for Influenza Split Vaccine without Inducing Inflammatory Responses.
Shirai S, Kawai A, Shibuya M, Munakata L, Omata D, Suzuki R, Yoshioka Y.
Shirai S, et al. Among authors: shibuya m.
Vaccines (Basel). 2020 Aug 3;8(3):433. doi: 10.3390/vaccines8030433.
Vaccines (Basel). 2020.
PMID: 32756368
Free PMC article.
Item in Clipboard
Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice.
Shibuya M, Aoshi T, Kuroda E, Yoshioka Y.
Shibuya M, et al.
J Virol. 2020 Jun 1;94(12):e00323-20. doi: 10.1128/JVI.00323-20. Print 2020 Jun 1.
J Virol. 2020.
PMID: 32269125
Free PMC article.
Item in Clipboard
Peptides with the multibasic cleavage site of the hemagglutinin from highly pathogenic influenza viruses act as cell-penetrating via binding to heparan sulfate and neuropilins.
Yamamoto Y, Tamiya S, Shibuya M, Nakase I, Yoshioka Y.
Yamamoto Y, et al. Among authors: shibuya m.
Biochem Biophys Res Commun. 2019 May 7;512(3):453-459. doi: 10.1016/j.bbrc.2019.03.068. Epub 2019 Mar 21.
Biochem Biophys Res Commun. 2019.
PMID: 30904159
Item in Clipboard
Cite
Cite